The drug KU-55933 was identified as an inhibitor of ATM [68] and was reported to suppresses cell proliferation and induce apoptosis [69], as well as increasing the TMZ responsiveness [70] and sensitizing radioresistant bladder cancer cells [71]. The gene discussed is ATM; the disease is urinary bladder carcinoma.